ARCHIVES

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

This article is from The Cancer Letter archive.

Vol. 05 No. 27 | July 6, 1979

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy

September 10, 1982

NCI-supported meeting included tobacco industry representatives in dialogue on ethics.

October 29, 2004

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

Et2’s Referral Guidelines

July 23, 1993

Acupuncture Eases Radiation-Induced Dry Mouth In Patients

April 24, 2009